Frontiers in Immunology (May 2021)

Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure

  • Verena Keitel,
  • Johannes Georg Bode,
  • Torsten Feldt,
  • Andreas Walker,
  • Lisa Müller,
  • Anselm Kunstein,
  • Caroline Klindt,
  • Alexander Killer,
  • Tina Senff,
  • Jörg Timm,
  • Philipp Ostermann,
  • Maximilian Damagnez,
  • Nadine Lübke,
  • Ortwin Adams,
  • Heiner Schaal,
  • Gerald Antoch,
  • Jennifer Neubert,
  • Philipp Albrecht,
  • Sven Meuth,
  • Saskia Elben,
  • Annemarie Mohring,
  • Johannes C. Fischer,
  • Edwin Bölke,
  • Manfred Hoenig,
  • Ansgar S. Schulz,
  • Tom Luedde,
  • Björn Jensen

DOI
https://doi.org/10.3389/fimmu.2021.645989
Journal volume & issue
Vol. 12

Abstract

Read online

We describe the unique disease course and cure of SARS-CoV-2 infection in a patient with SCID and graft failure. In absence of a humoral immune response, viral clearance was only achieved after transfusion of convalescent plasma. This observation underscores the necessity of the humoral immune response for SARS-CoV-2 clearance.

Keywords